Page last updated: 2024-08-23

anipamil and Coronary Disease

anipamil has been researched along with Coronary Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirchengast, M1
Nayler, WG; Panagiotopoulos, S1
Ceconi, C; Curello, S; Ferrari, R; Ghielmi, S; Raddino, R; Visioli, O1
MacLeod, BA; Moult, M; Saint, KM; Walker, MJ1
Kirkels, JH; Meijler, FL; Ruigrok, TJ; Van Echteld, CJ1
Brezinski, ME; Darius, H; Lefer, AM1
Curtis, MJ; Walker, MJ; Yuswack, T1

Other Studies

7 other study(ies) available for anipamil and Coronary Disease

ArticleYear
Differences in ischaemic myocardial potassium leakage after treatment with the calcium antagonist anipamil or the beta-blocker atenolol.
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:8

    Topics: Animals; Atenolol; Calcium Channel Blockers; Coronary Disease; Extracellular Space; Heart; Hemodynamics; Myocardium; Oxygen Consumption; Potassium; Propylamines; Swine

1990
Nicotine-induced calcium overload during postischemic reperfusion.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:6

    Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Female; Heart Rate; In Vitro Techniques; Nicotine; Norepinephrine; Perfusion; Phosphocreatine; Propylamines; Rats; Rats, Inbred Strains

1987
Prolonged protective effect of the calcium antagonist anipamil on the ischemic reperfused rabbit myocardium: comparison with verapamil.
    Cardiovascular drugs and therapy, 1989, Volume: 3, Issue:3

    Topics: Adenosine Triphosphate; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Creatine Kinase; In Vitro Techniques; Mitochondria, Heart; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Phosphocreatine; Propylamines; Proteins; Rabbits; Verapamil

1989
The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.
    British journal of pharmacology, 1989, Volume: 98, Issue:4

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Electrocardiography; Electrophysiology; Hemodynamics; Injections, Intravenous; Propylamines; Rats; Reperfusion Injury

1989
Protective effect of pretreatment with the calcium antagonist anipamil on the ischemic-reperfused rat myocardium: a phosphorus-31 nuclear magnetic resonance study.
    Journal of the American College of Cardiology, 1988, Volume: 11, Issue:5

    Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Hydrogen-Ion Concentration; Injections, Intraperitoneal; Intracellular Fluid; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardium; Phosphorus Radioisotopes; Premedication; Propylamines; Rats; Rats, Inbred Strains

1988
Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:3

    Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cats; Coronary Disease; Coronary Vessels; Creatine Kinase; Electrocardiography; Injections, Intra-Arterial; Male; Myocardium; Propylamines

1986
Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
    British journal of pharmacology, 1986, Volume: 88, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Electrocardiography; Heart Rate; Propylamines; Rats; Verapamil

1986